Skip to search.
 FTSE 100 Down 0.17%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
30.14 Up 0.39(1.31%) 2 Jul 21:00
Add to Portfolio
Prev Close:29.75
Open:29.69
Bid:29.75 x 400
Ask:32.10 x 100
1y Target Est:30.36
Beta:0.3
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:29.38 - 30.43
52wk Range:11.33 - 33.16
Volume:663,607
Avg Vol (3m):1,600,110
Market Cap:1.25b
P/E (ttm):N/A
EPS (ttm):-4.13
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTUp 1.31%1.25b
ALNYUp 0.23%9.93b
GSKUp 0.28%102.06b
ISISDown 1.80%6.72b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):336.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.83
Quarterly EPS Est (Jun-15) :-1.19
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):31.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback